Manage Account
Change Password
Sign Out
No dedicated clinical interaction studies have been performed.
Clinical experience has not given evidence for potential interaction of Recormon with other medicinal products (for more information see also Pharmacology: Toxicology: Nonclinical Safety: Other under Actions).
In animal experiments epoetin did not increase the myelotoxicity of cytostatic medicinal products like etoposide, cisplatin, cyclophosphamide and fluorouracil.
